Barclays Upgrades Illumina (ILMN) to Overweight Citing Better Conviction in Durability of NGS Revenue Growth

May 7, 2018 4:46 AM EDT
Get Alerts ILMN Hot Sheet
Price: $242.40 +0.89%

Rating Summary:
    14 Buy, 19 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 13 | New: 20
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Barclays upgraded Illumina (NASDAQ: ILMN) from Equalweight to Overweight with a price target of $300.00 (from $235.00).

Analyst Jack Meehan comments "We believe our proprietary NovaSeq customer survey provides an answer to the critical question for the Illumina thesis at the critical time: There is substantial elasticity of demand with customers who have adopted the NovaSeq system, which provides visibility into multiple years of double-digit growth for Illumina."

For an analyst ratings summary and ratings history on Illumina click here. For more ratings news on Illumina click here.

Shares of Illumina closed at $244.82 Friday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change, Hot Upgrades, Upgrades

Related Entities

Barclays